Latest Administration News

Structural Monitoring Systems Plc reports a profitable December quarter with 40% revenue growth, driven by strong avionics sales and progress toward FAA certification of its CVM™ technology.

Carnarvon Energy advances its Bedout Sub-basin exploration with a major drilling campaign planned for early 2027, while maintaining a robust financial position and strategic investment in Strike Energy.

Lindian Resources has accelerated development at its Kangankunde Rare Earths Project, securing full ownership and awarding key construction contracts, while attracting strategic international attention.

Kali Metals has completed its inaugural drilling campaign at the Marble Bar Gold Project and a comprehensive soil sampling program at Higginsville Lithium, with assay results anticipated in the first quarter of 2026.

Foresta Group Holdings has updated its share registry provider, extended its technology license with E3 Carbon, and deferred earthworks at its Kawerau project to Q3 2026, while maintaining a solid cash position.

Invex Therapeutics reports promising new data from its collaboration with Tessara Therapeutics on Exenatide’s potential in Alzheimer’s disease, alongside significant board changes and a solid cash position at quarter’s end.

OZZ Resources has entered a binding option agreement with Scorpion Minerals to sell its Maguires Reward project, securing an initial $100,000 fee and potential $2.5 million consideration pending shareholder approval. Exploration activity remained subdued across its portfolio during the December quarter.

InVert Graphite has completed its maiden drilling program at the Kumba deposit in Tanzania, revealing wide zones of high-grade graphite near surface and positioning the Morogoro Project for further advancement.

Sunstone Metals is seeking shareholder approval for a 30-for-1 share consolidation aimed at simplifying its capital structure and enhancing investor appeal. The move follows a recent placement that left the company with over 7 billion securities on issue.

LTR Pharma has initiated dosing in its Phase II clinical trial for SPONTAN, a rapid-acting intranasal spray targeting erectile dysfunction, marking a key step toward FDA approval and commercial expansion.

Kingston Resources reported a solid operating cash inflow of A$3 million for the December quarter, ending with nearly A$25 million in cash despite significant investing and financing outflows.

1414 Degrees updates on the administration of its joint venture partner Vast Solar Aurora, exploring acquisition options while progressing key renewable projects. The company also advances its October 2025 placement with shareholder-approved options now moving towards ASX quotation.